Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Swedish Orphan Biovitrum AB

+ Add to Watchlist

SOBI:SS

83.2000 SEK 0.3000 0.36%

As of 08:18:02 ET on 01/29/2015.

Snapshot for Swedish Orphan Biovitrum AB (SOBI)

Open: 83.5000 Day's Range: 82.6000 - 83.9000 Volume: 143,021
Previous Close: 83.5000 52wk Range: 65.0000 - 94.7500 1-Yr Rtn: +12.35%

Stock Chart for SOBI

No chart data available.
  • SOBI:SS 83.2000
  • 1D
  • 1M
  • 1Y
83.5000
Interactive SOBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SOBI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 200.8393
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -0.9700
Est. EPS (SEK) (12/2014) 0.4170
Est. PEG Ratio -
Market Cap (M SEK) 23,050.00
Shares Outstanding (M) 270.39
30 Day Average Volume 539,007
Price/Book (mrq) 4.8962
Price/Sale (ttm) 8.8367
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SOBI

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for SOBI

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Mats-Olof WallinSenior VP/CFOAlan RaffenspergerSenior VP/COO
Birgitte VolckSenior VP/Chief Medical OfcrHege HellstromVP/Head:Commercial
More Company Profile & Key Executives for SOBI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil